Conneqt Health Limited (CQT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Conneqt Health Limited (CQT) has a cash flow conversion efficiency ratio of 1.844x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-4.53 Million ≈ $-3.21 Million USD) by net assets (AU$-2.46 Million ≈ $-1.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Conneqt Health Limited for the company's overall valuation and market capitalisation.
Conneqt Health Limited - Cash Flow Conversion Efficiency Trend (2023–2025)
This chart illustrates how Conneqt Health Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Conneqt Health Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Conneqt Health Limited ranked by their cash flow conversion efficiency. See CQT debt coverage from operations to evaluate how effectively operating cash flow covers total debt obligations.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Charan Insurance Public Company Limited
BK:CHARAN
|
0.003x |
|
Bergenbio ASA
OL:BGBIO
|
-2.287x |
|
Global Interactive Technologies, Inc
NASDAQ:GITS
|
-0.134x |
|
KWESST MICRO SYS.INC.
F:62UA
|
-0.430x |
|
T3 Defense Inc.
NASDAQ:DFNS
|
-0.031x |
|
Paras Petrofils Limited
NSE:PARASPETRO
|
N/A |
|
Birks Group Inc
NYSE MKT:BGI
|
0.210x |
|
Identi Healthcare Ltd
TA:IDNT
|
-0.437x |
Annual Cash Flow Conversion Efficiency for Conneqt Health Limited (2023–2025)
The table below shows the annual cash flow conversion efficiency of Conneqt Health Limited from 2023 to 2025. View Conneqt Health Limited (CQT) stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$633.50K ≈ $448.24K |
AU$-10.90 Million ≈ $-7.71 Million |
-17.200x | -810.51% |
| 2024-06-30 | AU$4.09 Million ≈ $2.89 Million |
AU$-7.72 Million ≈ $-5.46 Million |
-1.889x | -111.79% |
| 2023-06-30 | AU$-748.40K ≈ $-529.54K |
AU$-12.00 Million ≈ $-8.49 Million |
16.029x | -- |
About Conneqt Health Limited
Conneqt Health Limited engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biometric technology that captures central hemodynamics and arterial stiffness for noninvasive measurement of vascular biomarkers including central aortic pressures and arterial stiffnes… Read more